Fullerene Derivative |
A23187 + FD* |
poly-L-lysine + FD* |
| Biotin |
83.9 (±8.0)¥¥¥ |
no Inh |
| C70-OH |
60.6 (±28.2)¥¥ |
16.41 (±10.5)¥ |
| CCC |
no Inh |
no Inh |
| DMAE |
41.1 (±12.9)¥ |
no Inh |
| Ethanolamine |
52.3 (±3.9)¥¥¥ |
no Inh |
| Niacin |
73.2 (±9.6)¥¥¥ |
no Inh |
| NSAID |
no Inh |
12.0 (±6.2)¥ |
| PC4 |
94.1 (±14.2)¥¥ |
no Inh |
| Tetraglutamate |
59.7 (±3.0)¥¥¥ |
48.3 (±1.86)¥¥¥ |
| Tetrainositol |
95.7 (±2.3)¥¥¥ |
72.4 (±6.7)¥¥¥ |
| Tetraphosphate |
39.3 (±14.3)¥ |
no Inh |
| Tetrapyridine |
51.7 (±17.5)¥¥ |
no Inh |
| Tetrasulfonate |
39.9 (±2.5)¥¥¥ |
no Inh |
| TGA |
93.7 (±4.6)¥¥¥ |
70.2 (±1.0)¥¥¥ |
| TTA |
98.7 (±3.6)¥¥¥ |
66.8 (±3.1)¥¥¥ |
* FD Treatment at 10 μg/mL.
¥¥¥ p value < 0.01 / ¥¥ p value < 0.02 / ¥ p value < 0.05
no Inh = no significant inhibition observed |
